PRiiMO

PRiiMOPRiiMO
PRiiMO

PRiiMO

AI-powered platform personalizing and optimizing cancer patient monitoring and treatment.

DR 2.12019Inactive1Tel Aviv, Israel
Rate

About

PRiiMO is developing an Artificial Intelligence (AI) based platform designed to personalize and optimize the monitoring and treatment of cancer patients. Their goal is to leverage AI to improve patient outcomes and streamline cancer care.
Frequently asked

What does PRiiMO do?

PRiiMO is developing an Artificial Intelligence (AI) based platform designed to personalize and optimize the monitoring and treatment of cancer patients. Their goal is to leverage AI to improve patient outcomes and streamline cancer care.

What is PRiiMO's revenue?

StartupHub estimates PRiiMO's annual revenue at $330K (range $186K to $583K, 68% confidence), based on comparable companies in the sector.

Where is PRiiMO headquartered?

PRiiMO is headquartered in Tel Aviv, Israel.

When was PRiiMO founded?

PRiiMO was founded in 2019.

What industry does PRiiMO operate in?

PRiiMO operates in Healthcare, Patient Support, Cancer, HealthTech, MedTech, AI-Driven Drug Discovery.

How many employees does PRiiMO have?

PRiiMO has approximately 1 people on record.

What is PRiiMO's current status?

PRiiMO's current operating status is: Inactive.

HEADCOUNT
1
DOMAIN RATING
2.1
Comments

No comments yet. Be the first to share your take.